Article Sidebar

PDF
Date Published: 19/12/2024
Abstract Views: 30
Views PDF: 6
DOI: 10.52322/jocmbmh.143.0210
Issue
Vol. 2 No. 143 (2024)
Section
How to papers
How to Cite
Nguyen Thi Tuyet, M., Vu Minh, P., & Phung Thi Thuy, H. (2024). CHARACTERISTICS OF NATURAL ANTICOAGULANT TESTS IN PATIENTS WITH THROMBOSIS AT BACH MAI HOSPITAL. Journal of Clinical Medicine Bach Mai Hospital, 2(143), 73-80. https://doi.org/10.52322/jocmbmh.143.0210

CHARACTERISTICS OF NATURAL ANTICOAGULANT TESTS IN PATIENTS WITH THROMBOSIS AT BACH MAI HOSPITAL

Mai Nguyen Thi Tuyet1, , Phuong Vu Minh1, Hanh Phung Thi Thuy1
1 Bach Mai Hospital

Author contact

  • Contact information: Mai Nguyen Thi Tuyet
  • Email:
  • Address: Bach Mai Hospital

Main Article Content

Abstract

Objective: To describe the rate of PS, PC, AT-III in the patients with thrombosis. Participants and Methods: A cross-sectional study on 360 patients with thrombosis at Bach Mai Hospital in 2022. Results: The average age of the study group of patients was 47.51 ± 15.6; 78% of patients had venous thromboembolism; the rate of decreased protein C was 23.6%, decreased protein S was 28.1% and decreased AT-III was 14.7%; the rate of patients with arterial thrombosis and venous thrombosis with decreased protein C was 23.1% and 23.8%, respectively; decreased protein S was 28% and 28.5%, respectively; decreased AT-III was 17.1% and 13.9%, respectively; The proportion of patients with venous thrombosis in the transverse sinus and lower limbs was higher than that of arterial thrombosis, and the proportion of patients with arterial thrombosis in the lungs and kidneys was higher than that of venous thrombosis. Conclusion: The proportion of patients with thrombosis who had decreased protein C, protein S, and antithrombin III was 23.6%; 28.1%, and 14.7%, respectively.

Keywords

natural anticoagulation, thrombosis, protein S, protein C, antithrombin III

Article Details

References

1. Hội Tim mạch học Việt Nam. Khuyến cáo về chẩn đoán, điều trị và dự phòng thuyên tắc huyết khối tĩnh mạch 2016. 2016.
2. Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 2009;23(5):225-229.
3. Ali N, Ayyub M, Khan SA. High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident. Pak J Med Sci. 2014;30(6):1323-1326.
4. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994;87(1):106-112.
5. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost. 1995;73(1):87-93.
6. Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med. 1987;317(16):991-996.
7. Heijboer H, Brandjes DP, Buller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med. 1990;323(22):1512-1516.
8. Koster T, Rosendaal FR, Briet E, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood. 1995;85(10):2756-2761.
9. Chen WH, Lu YC, Chen CM, et al. The prevalence of protein C, protein S, and antithrombin III deficiency in non-APS/SLE Chinese adults with noncardiac cerebral ischemia. Clin Appl Thromb Hemost. 2003;9(2):155-162.
10. Fall AO, Proulle V, Sall A, et al. Risk factors for thrombosis in an African population. Clin Med Insights Blood Disord. 2014;7:1-6.
11. Arachchillage DJ, Mackillop L, Chandratheva A, et al. Thrombophilia testing: a British Society for Haematology guideline. Br J Haematol. 2022;198(3):443-458.